INTENSITY THERAPEUTICS, INC. — All Filings
225 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001567264-24-000032 | Jun 4, 2024 | — |
| DEF 14A | DEF 14A | 0001567264-24-000031 | Jun 4, 2024 | — |
| ARS | ARS | 0001567264-24-000030 | Jun 4, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0001567264-24-000021 | May 24, 2024 | May 21, 2024 |
| 4 | FORM 4 | 0001567264-24-000019 | May 15, 2024 | May 14, 2024 |
| 3 | FORM 3 | 0001567264-24-000018 | May 15, 2024 | May 14, 2024 |
| 8-K | 8-K | 0001567264-24-000017 | May 15, 2024 | May 14, 2024 |
| 8-K | 8-K | 0001567264-24-000013 | May 10, 2024 | May 6, 2024 |
| 8-K | 8-K | 0001567264-24-000011 | May 9, 2024 | — |
| 10-Q | 10-Q | 0001567264-24-000010 | May 9, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0001567264-24-000003 | Apr 19, 2024 | Apr 18, 2024 |
| 8-K | 8-K | 0001628280-24-011219 | Mar 14, 2024 | — |
| 10-K | 10-K | 0001628280-24-011207 | Mar 14, 2024 | Dec 31, 2023 |
| 4 | — | 0001213900-24-020835 | Mar 7, 2024 | Mar 6, 2024 |
| 4 | — | 0001213900-24-020834 | Mar 7, 2024 | Mar 6, 2024 |
| 4 | — | 0001213900-24-020832 | Mar 7, 2024 | Mar 6, 2024 |
| 4 | — | 0001213900-24-020831 | Mar 7, 2024 | Mar 6, 2024 |
| 4 | — | 0001213900-24-020830 | Mar 7, 2024 | Mar 6, 2024 |
| SC 13G | SCHEDULE 13G | 0001213900-24-013266 | Feb 13, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-011098 | Feb 7, 2024 | Feb 6, 2024 |
| 4 | — | 0001213900-23-094886 | Dec 12, 2023 | Dec 11, 2023 |
| 3 | — | 0001213900-23-094885 | Dec 12, 2023 | Dec 11, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-094884 | Dec 12, 2023 | Dec 11, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-089612 | Nov 22, 2023 | Nov 21, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-085791 | Nov 13, 2023 | Sep 30, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-085558 | Nov 13, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-073586 | Sep 5, 2023 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-23-069897 | Aug 22, 2023 | — |
| 10-Q/A | AMENDMENT NO. 1 TO FORM 10-Q | 0001213900-23-067270 | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | QUARTERLY REPORT | 0001213900-23-066740 | Aug 14, 2023 | Jun 30, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-066456 | Aug 14, 2023 | — |
| 4 | — | 0001213900-23-058840 | Jul 21, 2023 | Jul 19, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-055658 | Jul 10, 2023 | — |
| 8-K | CURRENT REPORT | 0001213900-23-054818 | Jul 5, 2023 | Jun 29, 2023 |
| 424B4 | PROSPECTUS | 0001213900-23-053470 | Jun 30, 2023 | — |
| CERT | — | 0001354457-23-000444 | Jun 30, 2023 | — |
| SEC STAFF LETTER | — | 9999999997-23-003429 | Jun 29, 2023 | — |
| EFFECT | — | 9999999995-23-001911 | Jun 29, 2023 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-23-053086 | Jun 29, 2023 | — |
| 3 | — | 0001213900-23-053085 | Jun 29, 2023 | — |
| 3 | OWNERSHIP DOCUMENT | 0001213900-23-053084 | Jun 29, 2023 | — |
| 3 | — | 0001213900-23-053083 | Jun 29, 2023 | — |
| 3 | — | 0001213900-23-053082 | Jun 29, 2023 | — |
| 3 | — | 0001213900-23-053081 | Jun 29, 2023 | — |
| S-1MEF | REGISTRATION STATEMENT | 0001213900-23-053011 | Jun 29, 2023 | — |
| S-1/A | AMENDMENT NO. 16 TO FORM S-1 | 0001213900-23-052684 | Jun 29, 2023 | — |
| CORRESP | — | 0001213900-23-052008 | Jun 27, 2023 | — |
| CORRESP | — | 0001213900-23-052005 | Jun 27, 2023 | — |
| FWP | FREE WRITTING PROSPECTUS | 0001213900-23-051152 | Jun 23, 2023 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-23-051151 | Jun 23, 2023 | — |